ciprofloxacin has been researched along with Urethritis in 53 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Urethritis: Inflammation involving the URETHRA. Similar to CYSTITIS, clinical symptoms range from vague discomfort to painful urination (DYSURIA), urethral discharge, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the value of Tc-99m ciprofloxacin imaging in the differential diagnosis of chronic bacterial prostatitis." | 9.10 | Tc-99m ciprofloxacin imaging in diagnosis of chronic bacterial prostatitis. ( Choe, W; Kim, S; Lee, SM; Moon, Y; Pai, SH; Ryu, JK; Seong, DW; Suh, JK, 2003) |
| "The aim of this study was to compare the efficacy of single-dose pefloxacin 400 mg and ciprofloxacin 250 mg in the treatment of acute uncomplicated gonococcal urethritis in males." | 9.08 | Comparing the efficacy of pefloxacin and ciprofloxacin in the treatment of acute uncomplicated gonococcal urethritis in males. ( Chan, RK; Cheong, LL; Goh, CL; Leow, YH; Nadarajah, M, 1995) |
| "We compared 7-day regimens of ciprofloxacin in dosages of 750 and 1000 mg twice daily with doxycycline 100 mg twice daily for the treatment of nongonococcal urethritis in 178 men enrolled in a prospective, randomized, double-blind trial." | 9.06 | Ciprofloxacin compared with doxycycline for nongonococcal urethritis. Ineffectiveness against Chlamydia trachomatis due to relapsing infection. ( Ewers, C; Hooton, TM; Kuwamura, LE; Medina, TG; Roberts, PL; Rogers, ME; Stamm, WE, 1990) |
| "A randomized, double-blind study was performed in 225 men with nongonococcal urethritis or postgonococcal urethritis, in which the efficacy of ciprofloxacin (750 mg twice daily for seven days) was compared with that of doxycycline (100 mg twice daily for seven days)." | 9.06 | Treatment of nongonococcal urethritis with ciprofloxacin. ( Fong, IW; Linton, W; McLaughlin, B; Quinn, PA; Rahm, V; Simbul, M; Thorup, R, 1987) |
| "In a randomised study the clinical efficacy of ciprofloxacin was compared with that of doxycycline administered in two different dosage schemes to male patients suffering from non-gonococcal urethritis." | 9.06 | Clinical efficacy of ciprofloxacin versus doxycycline in the treatment of non-gonococcal urethritis in males. ( Habbema, L; Polak-Vogelzang, AA; van der Willigen, AH; Wagenvoort, JH, 1988) |
| "Eighty male patients with gonococcal urethritis were randomly allocated to receive, in an open study, either a single oral 400 mg dose of fleroxacin, or, as standard therapy, a single intramuscular dose of 2." | 9.06 | Fleroxacin versus standard therapy in gonococcal urethritis. ( Ellmén, J; Lassus, A; Renkonen, OV, 1988) |
| " We conducted a prospective, double-blind, randomized clinical trial of 250 mg of ciprofloxacin given orally versus 250 mg of ceftriaxone given intramuscularly for treatment of uncomplicated gonococcal urethritis in adult males." | 9.06 | Oral ciprofloxacin versus ceftriaxone for the treatment of urethritis from resistant Neisseria gonorrhoeae in Zambia. ( Brady, W; Bryan, JP; Hira, SK; Krieg, R; Luo, N; Mpoko, G; Mwale, C; Reichart, C; Siwiwaliondo, E; Waters, C, 1990) |
| "Two hundred and seventy-one male patients suffering from uncomplicated gonococcal urethritis were treated in an open randomized study with either 250 mg (121 patients) or 500 mg (150 patients) single oral doses of ciprofloxacin." | 9.06 | Oral ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in men. ( Angelucci, B; De Lalla, F; Rizzardini, G, 1987) |
| "To study the effectiveness of single-dose pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males." | 7.68 | Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males [corrected]. ( Chan, RK; Cheong, LL; Nadarajah, M, 1992) |
| "We performed basic and clinical studies on the effects of a new oral antimicrobial agent, fleroxacin (FLRX), a new quinolone derivative in male gonococcal urethritis." | 7.68 | [Bacteriological and clinical studies on fleroxacin in male gonococcal urethritis]. ( Hamaya, O; Miyamura, R; Ono, K; Saito, I; Suzuki, A; Yokozawa, M, 1991) |
| "Ciprofloxacin, a quinolone antibacterial, was evaluated in the treatment of gonococcal, chlamydial, gonococcal and chlamydial, and non-gonococcal non-chlamydial urethritis." | 7.67 | Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men. ( Arya, OP; Bartzokas, C; Hart, CA; Hobson, D; Pratt, BC, 1986) |
| "Seven patients (four men, three women) with gonococcal urethritis resistant to spectinomycin treatment were seen in May and June 1989 in the Department of Dermatology in Berlin (West), and strains of Neisseria gonorrhoeae (NG) resistant to spectinomycin were detected, cultured in vitro from these individuals." | 7.67 | [Spectinomycin resistant gonococcal infections in West Germany. Detection in 7 patients and occurrence of post-gonorrheal epididymitis caused by the spectinomycin-resistant PPNG strain]. ( Adler, M; Hörnle, R; Orfanos, CE; Stadler, R; Wagner, J, 1989) |
| "Ciprofloxacin would appear to be a very effective drug in the treatment of urethral gonorrhoea in males." | 6.66 | Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin. ( Michel, MF; Mooi, L; Stolz, E; Tegelberg-Stassen, MJ; van der Hoek, JC; van Joost, T; Wagenvoort, JH, 1986) |
| " Ciprofloxacin is effective in single dosage against urogenital gonococcal infections, and probably also against rectal and pharyngeal infections." | 6.37 | Ciprofloxacin in the treatment of gonorrhoea and non-gonococcal urethritis. ( Oriel, JD, 1986) |
| "The response of male gonococcal urethritis to a single 250 mg dose of ciprofloxacin versus 500 mg was studied." | 5.10 | Lower dose of ciprofloxacin is adequate for the treatment of Neisseria gonorrhoeae in KwaZulu Natal, South Africa. ( Coovadia, YM; Moodley, P; Nzimande, G; Pillay, C; Sturm, AW, 2002) |
| "To investigate the value of Tc-99m ciprofloxacin imaging in the differential diagnosis of chronic bacterial prostatitis." | 5.10 | Tc-99m ciprofloxacin imaging in diagnosis of chronic bacterial prostatitis. ( Choe, W; Kim, S; Lee, SM; Moon, Y; Pai, SH; Ryu, JK; Seong, DW; Suh, JK, 2003) |
| "The aim of this study was to compare the efficacy of single-dose pefloxacin 400 mg and ciprofloxacin 250 mg in the treatment of acute uncomplicated gonococcal urethritis in males." | 5.08 | Comparing the efficacy of pefloxacin and ciprofloxacin in the treatment of acute uncomplicated gonococcal urethritis in males. ( Chan, RK; Cheong, LL; Goh, CL; Leow, YH; Nadarajah, M, 1995) |
| " We conducted a prospective, double-blind, randomized clinical trial of 250 mg of ciprofloxacin given orally versus 250 mg of ceftriaxone given intramuscularly for treatment of uncomplicated gonococcal urethritis in adult males." | 5.06 | Oral ciprofloxacin versus ceftriaxone for the treatment of urethritis from resistant Neisseria gonorrhoeae in Zambia. ( Brady, W; Bryan, JP; Hira, SK; Krieg, R; Luo, N; Mpoko, G; Mwale, C; Reichart, C; Siwiwaliondo, E; Waters, C, 1990) |
| "We compared 7-day regimens of ciprofloxacin in dosages of 750 and 1000 mg twice daily with doxycycline 100 mg twice daily for the treatment of nongonococcal urethritis in 178 men enrolled in a prospective, randomized, double-blind trial." | 5.06 | Ciprofloxacin compared with doxycycline for nongonococcal urethritis. Ineffectiveness against Chlamydia trachomatis due to relapsing infection. ( Ewers, C; Hooton, TM; Kuwamura, LE; Medina, TG; Roberts, PL; Rogers, ME; Stamm, WE, 1990) |
| "In a randomised study the clinical efficacy of ciprofloxacin was compared with that of doxycycline administered in two different dosage schemes to male patients suffering from non-gonococcal urethritis." | 5.06 | Clinical efficacy of ciprofloxacin versus doxycycline in the treatment of non-gonococcal urethritis in males. ( Habbema, L; Polak-Vogelzang, AA; van der Willigen, AH; Wagenvoort, JH, 1988) |
| "Eighty male patients with gonococcal urethritis were randomly allocated to receive, in an open study, either a single oral 400 mg dose of fleroxacin, or, as standard therapy, a single intramuscular dose of 2." | 5.06 | Fleroxacin versus standard therapy in gonococcal urethritis. ( Ellmén, J; Lassus, A; Renkonen, OV, 1988) |
| "The results of two therapeutic trials in female patients with uncomplicated urogenital gonorrhoea (A) and in male patients with uncomplicated urethral gonorrhoea (B) treated with either 200 mg and 400 mg enoxacin orally, of one therapeutic trial in male patients with uncomplicated urogenital gonorrhoea treated with either 250 mg or 500 mg ciprofloxacin orally (C) and of one therapeutic trial in male patients with non-gonococcal urethritis (NGU) treated with ciprofloxacin 1 g daily during seven days (D) are presented and compared with the results of other investigators." | 5.06 | Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections. ( Stolz, E; van der Willigen, AH; Wagenvoort, JH, 1987) |
| "Two hundred and seventy-one male patients suffering from uncomplicated gonococcal urethritis were treated in an open randomized study with either 250 mg (121 patients) or 500 mg (150 patients) single oral doses of ciprofloxacin." | 5.06 | Oral ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in men. ( Angelucci, B; De Lalla, F; Rizzardini, G, 1987) |
| "A randomized, double-blind study was performed in 225 men with nongonococcal urethritis or postgonococcal urethritis, in which the efficacy of ciprofloxacin (750 mg twice daily for seven days) was compared with that of doxycycline (100 mg twice daily for seven days)." | 5.06 | Treatment of nongonococcal urethritis with ciprofloxacin. ( Fong, IW; Linton, W; McLaughlin, B; Quinn, PA; Rahm, V; Simbul, M; Thorup, R, 1987) |
| " A few days before he had been treated with ciprofloxacine 500mg bid for chlamydial urethritis." | 3.74 | [Fluorquinolone associated tendon rupture]. ( Bürr, P; Haschke, M; Rätz Bravo, A; Stoll, R, 2008) |
| "Johannesburg and Cape Town have witnessed significant rises in the prevalence of ciprofloxacin-resistant gonorrhoea among men with urethritis." | 3.74 | Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two South African cities: association with HIV seropositivity. ( du Plessis, N; Lewis, DA; Mhlongo, S; Radebe, F; Scott, L; Sello, M; Slabbert, M; van Zijl, A; Wasserman, E, 2008) |
| "Syndromic management guidelines for male urethritis syndrome and female discharge syndrome (nonpregnant) in South Africa advocate the use of ciprofloxacin for potential infection with Neisseria gonorrhoeae." | 3.73 | Molecular epidemiology of recently emergent ciprofloxacin-resistant Neisseria gonorrhoeae in South Africa. ( Ison, CA; Martin, IM; Moodley, P; Pillay, K; Sturm, AW, 2006) |
| "To describe the emergence of and risk factors for gonococcal urethritis caused by gonococci with decreased susceptibility to ciprofloxacin." | 3.69 | The emergence of Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: epidemiology and risk factors. ( Carlyn, CJ; Doyle, LJ; Gordon, SM; Hall, GS; Knapp, CC; Longworth, DL; Washington, JA, 1996) |
| "To study the effectiveness of single-dose pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males." | 3.68 | Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males [corrected]. ( Chan, RK; Cheong, LL; Nadarajah, M, 1992) |
| "We performed basic and clinical studies on the effects of a new oral antimicrobial agent, fleroxacin (FLRX), a new quinolone derivative in male gonococcal urethritis." | 3.68 | [Bacteriological and clinical studies on fleroxacin in male gonococcal urethritis]. ( Hamaya, O; Miyamura, R; Ono, K; Saito, I; Suzuki, A; Yokozawa, M, 1991) |
| "Ciprofloxacin, a quinolone antibacterial, was evaluated in the treatment of gonococcal, chlamydial, gonococcal and chlamydial, and non-gonococcal non-chlamydial urethritis." | 3.67 | Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men. ( Arya, OP; Bartzokas, C; Hart, CA; Hobson, D; Pratt, BC, 1986) |
| "Seven patients (four men, three women) with gonococcal urethritis resistant to spectinomycin treatment were seen in May and June 1989 in the Department of Dermatology in Berlin (West), and strains of Neisseria gonorrhoeae (NG) resistant to spectinomycin were detected, cultured in vitro from these individuals." | 3.67 | [Spectinomycin resistant gonococcal infections in West Germany. Detection in 7 patients and occurrence of post-gonorrheal epididymitis caused by the spectinomycin-resistant PPNG strain]. ( Adler, M; Hörnle, R; Orfanos, CE; Stadler, R; Wagner, J, 1989) |
| "A single oral dose of ciprofloxacin 500 mg was used to treat five men with gonococcal urethritis and five men with gonococcal proctitis, and all were cured." | 3.67 | Single dose ciprofloxacin for treating gonococcal infections in men. ( Loo, PS; Oriel, JD; Ridgway, GL, 1985) |
| "Gonorrhea, trichomoniasis, chlamydiosis and Ureaplasma infection were detected in 60, 31." | 2.67 | [Ofloxacin and ciprofloxacin in the treatment of sexually-transmitted diseases]. ( Bakalova, LA; Bednova, VN; Bugrov, AV; Kisina, VI; Navolotskaia, TI; Vakhnina, TE, 1992) |
| "Ciprofloxacin would appear to be a very effective drug in the treatment of urethral gonorrhoea in males." | 2.66 | Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin. ( Michel, MF; Mooi, L; Stolz, E; Tegelberg-Stassen, MJ; van der Hoek, JC; van Joost, T; Wagenvoort, JH, 1986) |
| " Ciprofloxacin is effective in single dosage against urogenital gonococcal infections, and probably also against rectal and pharyngeal infections." | 2.37 | Ciprofloxacin in the treatment of gonorrhoea and non-gonococcal urethritis. ( Oriel, JD, 1986) |
| "Trichomoniasis was detected in 4." | 1.35 | The detection of urethritis pathogens among patients with the male urethritis syndrome, genital ulcer syndrome and HIV voluntary counselling and testing clients: should South Africa's syndromic management approach be revised? ( Black, V; Lewis, DA; Magooa, P; Myers, M; Pillay, C; Radebe, F, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (32.08) | 18.7374 |
| 1990's | 15 (28.30) | 18.2507 |
| 2000's | 17 (32.08) | 29.6817 |
| 2010's | 4 (7.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Affolabi, D | 1 |
| Goma, E | 1 |
| Sogbo, F | 1 |
| Ahotin, G | 1 |
| Orekan, J | 1 |
| Massou, F | 1 |
| Behanzin, L | 1 |
| Guédou, F | 1 |
| Alary, M | 1 |
| Rebick, GW | 1 |
| Allen, VG | 1 |
| Gold, WL | 1 |
| Babics, A | 1 |
| Roussellier, P | 1 |
| Su, XH | 1 |
| Wang, BX | 1 |
| Le, WJ | 1 |
| Liu, YR | 1 |
| Wan, C | 1 |
| Li, S | 1 |
| Alm, RA | 1 |
| Mueller, JP | 1 |
| Rice, PA | 1 |
| Lewis, DA | 3 |
| Scott, L | 1 |
| Slabbert, M | 1 |
| Mhlongo, S | 1 |
| van Zijl, A | 1 |
| Sello, M | 1 |
| du Plessis, N | 1 |
| Radebe, F | 2 |
| Wasserman, E | 1 |
| Rätz Bravo, A | 1 |
| Stoll, R | 1 |
| Bürr, P | 1 |
| Haschke, M | 1 |
| Chowdhry, S | 1 |
| Pandhi, D | 1 |
| Vidhani, S | 1 |
| Bhalla, P | 1 |
| Reddy, BS | 1 |
| Sieper, J | 1 |
| Braun, J | 1 |
| Moodley, P | 3 |
| Pillay, C | 2 |
| Nzimande, G | 1 |
| Coovadia, YM | 1 |
| Sturm, AW | 2 |
| Chaudhry, U | 1 |
| Ray, K | 1 |
| Bala, M | 1 |
| Saluja, D | 1 |
| Ryu, JK | 1 |
| Lee, SM | 1 |
| Seong, DW | 1 |
| Suh, JK | 1 |
| Kim, S | 1 |
| Choe, W | 1 |
| Moon, Y | 1 |
| Pai, SH | 1 |
| Moodley, D | 1 |
| Willem Sturm, A | 1 |
| Martin, IM | 1 |
| Pillay, K | 1 |
| Ison, CA | 2 |
| Sethi, S | 1 |
| Sharma, D | 1 |
| Mehta, SD | 1 |
| Singh, B | 1 |
| Smriti, M | 1 |
| Kumar, B | 1 |
| Sharma, M | 1 |
| Rackstraw, S | 1 |
| Viswalingam, ND | 1 |
| Goh, BT | 2 |
| De Jongh, M | 1 |
| Dangor, Y | 1 |
| Hoosen, AA | 1 |
| Black, V | 1 |
| Magooa, P | 1 |
| Myers, M | 1 |
| Jain, SK | 1 |
| Kulkarni, MG | 2 |
| Banker, DD | 1 |
| Forster, GE | 1 |
| Tanaka, M | 2 |
| Kumazawa, J | 1 |
| Matsumoto, T | 1 |
| Kobayashi, I | 1 |
| Moi, H | 2 |
| Morel, P | 2 |
| Gianotti, B | 2 |
| Barlow, D | 2 |
| Phillips, I | 3 |
| Jean, C | 2 |
| Gordon, SM | 1 |
| Carlyn, CJ | 1 |
| Doyle, LJ | 1 |
| Knapp, CC | 1 |
| Longworth, DL | 1 |
| Hall, GS | 1 |
| Washington, JA | 1 |
| Leow, YH | 1 |
| Chan, RK | 2 |
| Cheong, LL | 2 |
| Goh, CL | 1 |
| Nadarajah, M | 2 |
| Nakayama, H | 1 |
| Haraoka, M | 1 |
| Saika, T | 1 |
| Pai, A | 1 |
| Koppikar, GV | 1 |
| David, N | 1 |
| Wildman, G | 1 |
| Rajamanoharan, S | 1 |
| Llanes, R | 1 |
| Sosa, J | 1 |
| Guzmán, D | 1 |
| Gutiérrez, Y | 1 |
| Llop, A | 1 |
| Ricardo, O | 1 |
| Bednova, VN | 1 |
| Bakalova, LA | 1 |
| Bugrov, AV | 1 |
| Navolotskaia, TI | 1 |
| Kisina, VI | 1 |
| Vakhnina, TE | 1 |
| Tapsall, JW | 1 |
| Shultz, TR | 1 |
| Lovett, R | 1 |
| Munro, R | 1 |
| Saito, I | 1 |
| Suzuki, A | 1 |
| Yokozawa, M | 1 |
| Ono, K | 1 |
| Miyamura, R | 1 |
| Hamaya, O | 1 |
| Bryan, JP | 1 |
| Hira, SK | 1 |
| Brady, W | 1 |
| Luo, N | 1 |
| Mwale, C | 1 |
| Mpoko, G | 1 |
| Krieg, R | 1 |
| Siwiwaliondo, E | 1 |
| Reichart, C | 1 |
| Waters, C | 1 |
| Hooton, TM | 1 |
| Rogers, ME | 1 |
| Medina, TG | 1 |
| Kuwamura, LE | 1 |
| Ewers, C | 1 |
| Roberts, PL | 1 |
| Stamm, WE | 1 |
| Bowie, WR | 1 |
| Willetts, V | 1 |
| Megran, DW | 1 |
| Orfanos, CE | 1 |
| Adler, M | 1 |
| Hörnle, R | 1 |
| Stadler, R | 1 |
| Wagner, J | 1 |
| Jeskanen, L | 1 |
| Karppinen, L | 1 |
| Ingervo, L | 1 |
| Reitamo, S | 1 |
| Happonen, HP | 1 |
| Lassus, A | 2 |
| Loo, PS | 1 |
| Ridgway, GL | 1 |
| Oriel, JD | 2 |
| Tegelberg-Stassen, MJ | 1 |
| van der Hoek, JC | 1 |
| Mooi, L | 1 |
| Wagenvoort, JH | 3 |
| van Joost, T | 1 |
| Michel, MF | 1 |
| Stolz, E | 2 |
| Shahmanesh, M | 1 |
| Shukla, SR | 1 |
| Westwood, A | 1 |
| Thin, RN | 1 |
| Arya, OP | 1 |
| Hobson, D | 1 |
| Hart, CA | 1 |
| Bartzokas, C | 1 |
| Pratt, BC | 1 |
| Roddy, RE | 1 |
| Handsfield, HH | 1 |
| Hook, EW | 1 |
| Okazaki, T | 1 |
| Kiyota, H | 1 |
| Gotoh, H | 1 |
| van der Willigen, AH | 2 |
| Polak-Vogelzang, AA | 1 |
| Habbema, L | 1 |
| Renkonen, OV | 1 |
| Ellmén, J | 1 |
| Pust, RA | 1 |
| Ackenheil-Köppe, HR | 1 |
| Weidner, W | 1 |
| Meier-Ewert, H | 1 |
| De Lalla, F | 1 |
| Rizzardini, G | 1 |
| Angelucci, B | 1 |
| Fong, IW | 1 |
| Linton, W | 1 |
| Simbul, M | 1 |
| Thorup, R | 1 |
| McLaughlin, B | 1 |
| Rahm, V | 1 |
| Quinn, PA | 1 |
| Monteiro, E | 1 |
| Kinghorn, GR | 1 |
| Spencer, RC | 1 |
4 reviews available for ciprofloxacin and Urethritis
| Article | Year |
|---|---|
A 34-year-old man with urethral discharge.
Topics: Adult; Ciprofloxacin; Drug Therapy, Combination; Follow-Up Studies; Gonorrhea; Homosexuality, Male; | 2013 |
[Diagnosis and antibiotic treatment of reactive arthritis].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Arthritis, Reactive; A | 2002 |
[Antibiotherapy applied to uncomplicated urethritis and cervicitis. French Agency for Health Product Safety].
Topics: Anti-Bacterial Agents; Asia; Chlamydia Infections; Ciprofloxacin; Drug Resistance, Multiple, Bacteri | 2006 |
Ciprofloxacin in the treatment of gonorrhoea and non-gonococcal urethritis.
Topics: 4-Quinolones; Anti-Infective Agents; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia | 1986 |
17 trials available for ciprofloxacin and Urethritis
| Article | Year |
|---|---|
Lower dose of ciprofloxacin is adequate for the treatment of Neisseria gonorrhoeae in KwaZulu Natal, South Africa.
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Doxycycline; Drug Administra | 2002 |
Tc-99m ciprofloxacin imaging in diagnosis of chronic bacterial prostatitis.
Topics: Adult; Aged; Bacterial Infections; Chronic Disease; Ciprofloxacin; Humans; Male; Middle Aged; Organo | 2003 |
Efficacy and safety of single oral dose sparfloxacin vs ciprofloxacin in acute gonococcal urethritis in males. A multicentre international study.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Fluoroquinolones; G | 1995 |
Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Double | 1996 |
Comparing the efficacy of pefloxacin and ciprofloxacin in the treatment of acute uncomplicated gonococcal urethritis in males.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Anti-Infective Agents, Urinary; beta-Lactam | 1995 |
[Ofloxacin and ciprofloxacin in the treatment of sexually-transmitted diseases].
Topics: Chlamydia Infections; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female | 1992 |
Oral ciprofloxacin versus ceftriaxone for the treatment of urethritis from resistant Neisseria gonorrhoeae in Zambia.
Topics: Adult; Ceftriaxone; Chlamydia trachomatis; Ciprofloxacin; Double-Blind Method; Drug Resistance, Micr | 1990 |
Ciprofloxacin compared with doxycycline for nongonococcal urethritis. Ineffectiveness against Chlamydia trachomatis due to relapsing infection.
Topics: Adult; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Doxycycline; Follow-Up Studies; H | 1990 |
Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Ciprofl | 1989 |
Ciprofloxacin versus doxycycline in the treatment of uncomplicated urogenital Chlamydia trachomatis infections. A double-blind comparative study.
Topics: Adult; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Clinical Trials as Topic; Double- | 1989 |
Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Gonorrhea; Humans; Ma | 1986 |
Comparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men.
Topics: Adolescent; Adult; Ampicillin; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Clinical | 1986 |
Clinical efficacy of ciprofloxacin versus doxycycline in the treatment of non-gonococcal urethritis in males.
Topics: Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Doxycycline; Humans; Male; Mycoplasmatal | 1988 |
Fleroxacin versus standard therapy in gonococcal urethritis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Follow-Up Studies; Gonorrhea; Humans; Male; | 1988 |
Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia trachomatis | 1987 |
Oral ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in men.
Topics: Administration, Oral; Adolescent; Adult; Ciprofloxacin; Clinical Trials as Topic; Drug Evaluation; G | 1987 |
Treatment of nongonococcal urethritis with ciprofloxacin.
Topics: Adult; Chlamydia Infections; Ciprofloxacin; Clinical Trials as Topic; Digestive System; Double-Blind | 1987 |
32 other studies available for ciprofloxacin and Urethritis
| Article | Year |
|---|---|
Antimicrobial susceptibility profile of
Topics: Anti-Bacterial Agents; Benin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fema | 2018 |
Gardnerella vaginalis: An overlooked pathogen in male patients?
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, | 2015 |
Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914).
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Ciprofloxacin; DNA Gyrase; Drug Resi | 2016 |
Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two South African cities: association with HIV seropositivity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial | 2008 |
[Fluorquinolone associated tendon rupture].
Topics: Achilles Tendon; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anti-Bacte | 2008 |
High incidence of treatment failure of Neisseria gonorrhoeae isolates to ciprofloxacin in male gonococcal urethritis in Delhi.
Topics: Anti-Infective Agents; Ciprofloxacin; Gonorrhea; Humans; Incidence; Male; Microbial Sensitivity Test | 2002 |
Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; | 2002 |
Ciprofloxacin resistant Neisseria gonorrhoeae in South Africa.
Topics: Adolescent; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Hum | 2004 |
Molecular epidemiology of recently emergent ciprofloxacin-resistant Neisseria gonorrhoeae in South Africa.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial | 2006 |
Emergence of ciprofloxacin resistant Neisseria gonorrhoeae in north India.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; India; Male; Mi | 2006 |
Can chlamydial conjunctivitis result from direct ejaculation into the eye?
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cervix Uteri; Chlamydia Infection | 2006 |
Neisseria gonorrhoeae multi-antigen sequence typing (NG-MAST) of ciprofloxacin resistant isolates of Pretoria, South Africa.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Ciprofloxacin; Drug Resistance, Bacterial; Genes | 2008 |
The detection of urethritis pathogens among patients with the male urethritis syndrome, genital ulcer syndrome and HIV voluntary counselling and testing clients: should South Africa's syndromic management approach be revised?
Topics: Ceftriaxone; Ciprofloxacin; Counseling; Drug Resistance, Microbial; Gonorrhea; HIV Infections; Human | 2008 |
Antibiotic susceptibility pattern of gonococcal isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Neisseria | 1994 |
Ciprofloxacin resistant gonococci arriving from Thailand.
Topics: Adult; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Ur | 1994 |
High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan.
Topics: Chi-Square Distribution; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Microbi | 1994 |
The emergence of Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: epidemiology and risk factors.
Topics: Anti-Infective Agents; Case-Control Studies; Ciprofloxacin; Electrophoresis, Gel, Pulsed-Field; Geno | 1996 |
National guideline for the management of gonorrhoea in adults. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Contact Tracing; Female; Gonorrhea; Humans; | 1999 |
Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998.
Topics: Amino Acid Substitution; Amino Acids; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Typing | 2000 |
Antibiotics sensitivity pattern of N. gonorrhoeae with special emphasis on norfloxacin and ciprofloxacin.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Gonorrhea; Humans; Ma | 1999 |
Ciprofloxacin 250 mg for treating gonococcal urethritis and cervicitis.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Gonorrh | 2000 |
Neisseria gonorrhoeae resistant to ciprofloxacin: first report in Cuba.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cuba; Drug Resistance, Microbial; Gonorrhea; Humans; Ma | 2001 |
Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males [corrected].
Topics: 4-Quinolones; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Drug Ad | 1992 |
Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhoea.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Urethritis | 1992 |
[Bacteriological and clinical studies on fleroxacin in male gonococcal urethritis].
Topics: Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Drug Evaluation; Drug Resistance, Micr | 1991 |
[Spectinomycin resistant gonococcal infections in West Germany. Detection in 7 patients and occurrence of post-gonorrheal epididymitis caused by the spectinomycin-resistant PPNG strain].
Topics: Adolescent; Adult; Cefotaxime; Ciprofloxacin; Epididymitis; Female; Gonorrhea; Humans; Male; Neisser | 1989 |
Single dose ciprofloxacin for treating gonococcal infections in men.
Topics: Anti-Infective Agents; Chlamydia Infections; Ciprofloxacin; Gonorrhea; Humans; Male; Pharyngitis; Pr | 1985 |
Ciprofloxacin for treating urethral gonorrhoea in men.
Topics: Ciprofloxacin; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Penicillinase; Quinolines; Urethritis | 1986 |
Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men.
Topics: Adult; Chlamydia Infections; Ciprofloxacin; Drug Evaluation; Gonorrhea; Humans; Male; Quinolines; Ur | 1986 |
[Bacteriological and clinical study of ciprofloxacin in gonococcal urethritis].
Topics: Administration, Oral; Adult; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Mid | 1986 |
Clinical efficacy and tolerance of fleroxacin in patients with urethritis caused by Chlamydia trachomatis.
Topics: Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Drug Tolerance; F | 1988 |
Quinolones in non-gonococcal urethritis.
Topics: Ciprofloxacin; Humans; Male; Urethritis | 1986 |